{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:22:07Z","timestamp":1795112527925,"version":"4.10.3"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Although endometrial carcinoma (EC) is generally considered to have a good prognosis, over 20% of women with EC die of their disease, with a projected increase in both incidence and mortality over the next few decades. The aim of accurate prognostication is to ensure that patients receive optimal treatment and are neither overtreated nor undertreated, thereby improving patient outcomes overall. Patients with EC can be categorized into prognostic risk groups based on clinicopathologic findings. Other than tumor type and grade, groupings and recommended management algorithms may take into account age, body mass index, stage, and presence of lymphovascular space invasion. The molecular classification of EC that has emerged from the Cancer Genome Atlas (TCGA) study provides additional, potentially superior, prognostic information to traditional histologic typing and grading. This classifier does not, however, replace clinicopathologic risk assessment based on parameters other than histotype and grade. It is envisaged that molecular and clinicopathologic prognostic grouping systems will work better together than either alone. Thus, while tumor typing and grading may be superseded by a classification based on underlying genomic abnormalities, accurate assessment of other pathologic parameters will continue to be key to patient management. These include those factors related to staging, such as depth of myometrial invasion, cervical, vaginal, serosal surface, adnexal and parametrial invasion, and those independent of stage such as lymphovascular space invasion. Other prognostic parameters will also be discussed. These recommendations were developed from the International Society of Gynecological Pathologists Endometrial Carcinoma project.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000524","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T02:58:00Z","timestamp":1544842680000},"page":"S93-S113","source":"Crossref","is-referenced-by-count":159,"title":["Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)"],"prefix":"10.1097","volume":"38","author":[{"given":"Naveena","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Hirschowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Zaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Alvarado-Cabrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maire A.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouba","family":"Ali-Fehmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Euscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Christian","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ioffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Ordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ruhul","family":"Quddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Staebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Zaloudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Malpica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann Oncol"},{"issue":"suppl 4","key":"R3-20230824","doi-asserted-by":"crossref","first-page":"iv153","DOI":"10.1093\/annonc\/mdx243","article-title":"Appendix 5: endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org\/Guidelines\/Gynaecological-Cancers)","volume":"28","author":"Colombo","year":"2017","journal-title":"Ann Oncol"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC Cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/annonc\/mdx753","article-title":"Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer","volume":"29","author":"de Boer","year":"2018","journal-title":"Ann Oncol"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/PAS.0b013e31815a04f5","article-title":"Mandatory second opinion in surgical pathology referral material: clinical consequences of major disagreements","volume":"32","author":"Manion","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0360-3016(00)00791-4","article-title":"An analysis of the impact of pathology review in gynecologic cancer","volume":"48","author":"Chafe","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0090-8258(03)00323-8","article-title":"Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy","volume":"90","author":"Khalifa","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.pgp.0000233165.56385.0b","article-title":"Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma","volume":"26","author":"Ali","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PAS.0b013e3182073ac0","article-title":"Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study","volume":"35","author":"McCluggage","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PGP.0b013e31825d808b","article-title":"Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia","volume":"32","author":"McCluggage","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.pgp.0000177123.78932.1d","article-title":"Assessment of uterine wall thickness and position of the vascular plexus in the deep myometrium: implications for the measurement of depth of myometrial invasion of endometrial carcinomas","volume":"25","author":"Williams","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/his.12058","article-title":"Problematic issues in the staging of endometrial, cervical and vulval carcinomas","volume":"62","author":"Hirschowitz","year":"2013","journal-title":"Histopathology"},{"issue":"suppl 1","key":"R20-20230824","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1038\/modpathol.2015.127","article-title":"Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome","volume":"29","author":"Soslow","year":"2016","journal-title":"Mod Pathol"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0090-8258(90)90376-V","article-title":"Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases","volume":"37","author":"Jacques","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/PGP.0b013e3181d81de6","article-title":"The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma","volume":"29","author":"Hanley","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1245\/s10434-014-3880-6","article-title":"Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer","volume":"21","author":"Matsuo","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/gyno.1993.1107","article-title":"Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis","volume":"49","author":"Mittal","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.anndiagpath.2006.08.011","article-title":"Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion","volume":"11","author":"Ismiil","year":"2007","journal-title":"Ann Diagn Pathol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.pgp.0000235064.93182.ec","article-title":"Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma","volume":"26","author":"Ismiil","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/IGC.0000000000000243","article-title":"Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma","volume":"24","author":"Taneichi","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","article-title":"Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance","volume":"22","author":"Murray","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/00313020903041135","article-title":"MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion","volume":"41","author":"Stewart","year":"2009","journal-title":"Pathology"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/his.12254","article-title":"Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma","volume":"64","author":"Han","year":"2014","journal-title":"Histopathology"},{"issue":"suppl 1","key":"R32-20230824","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/modpathol.2015.142","article-title":"How to approach the many faces of endometrioid carcinoma","volume":"29","author":"Malpica","year":"2016","journal-title":"Mod Pathol"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0360-3016(02)02813-4","article-title":"Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients","volume":"53","author":"Pitson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2012.09.035","article-title":"Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible","volume":"128","author":"Zaino","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2009.03.007","article-title":"Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion","volume":"113","author":"Orezzoli","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.humpath.2015.06.015","article-title":"Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma","volume":"46","author":"Roma","year":"2015","journal-title":"Hum Pathol"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/00000478-200308000-00005","article-title":"Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion","volume":"27","author":"Tambouret","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/AOG.0b013e3181f73fc2","article-title":"Cervical stromal invasion predicting survival in endometrial cancer","volume":"116","author":"Ferriss","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/gyno.1999.5415","article-title":"The significance of adnexal involvement in endometrial carcinoma","volume":"74","author":"Connell","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R42-20230824","doi-asserted-by":"crossref","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"djv427","DOI":"10.1093\/jnci\/djv427","article-title":"Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas","volume":"108","author":"Schultheis","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R45-20230824","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/PAS.0b013e31820273dc","article-title":"Histologic artifacts in abdominal, vaginal, laparoscopic, and robotic hysterectomy specimens: a blinded, retrospective review","volume":"35","author":"Krizova","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R46-20230824","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/PGP.0b013e31825f7c08","article-title":"Tumoral displacement into fallopian tubes in patients undergoing robotically assisted hysterectomy for newly diagnosed endometrial cancer","volume":"32","author":"Delair","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"R47-20230824","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.pgp.0000179614.47838.82","article-title":"Transtubal spread of serous adenocarcinoma of the endometrium: an underrecognized mechanism of metastasis","volume":"25","author":"Snyder","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R48-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv158","article-title":"Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG Oncology\/Gynecologic Oncology Group 210 Trial","volume":"107","author":"Felix","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R49-20230824","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PAT.0b013e328360b6e7","article-title":"Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis","volume":"45","author":"Stewart","year":"2013","journal-title":"Pathology"},{"key":"R50-20230824","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000000293","article-title":"Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia","volume":"39","author":"Rabban","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R51-20230824","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000000757","article-title":"Uterine serous carcinomas frequently metastasize to the fallopian tube and can mimic serous tubal intraepithelial carcinoma","volume":"41","author":"Kommoss","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R52-20230824","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","article-title":"Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance","volume":"28","author":"Jarboe","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R53-20230824","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/PGP.0b013e3181c1158e","article-title":"Coexisting serous carcinoma of the endometrium and the fallopian tube","volume":"29","author":"Stewart","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R54-20230824","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3346\/jkms.2010.25.4.552","article-title":"Necessity of radical hysterectomy for endometrial cancer patients with cervical invasion","volume":"25","author":"Lee","year":"2010","journal-title":"J Korean Med Sci"},{"key":"R55-20230824","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0020-7292(02)00383-1","article-title":"Parametrial tumor spreading patterns in cervix cancer patients treated by radical hysterectomy","volume":"80","author":"Yen","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"R56-20230824","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181f80a49","article-title":"Evaluation of parametrial spread in endometrial carcinoma","volume":"116","author":"Watanabe","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R57-20230824","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1701-2163(15)30966-X","article-title":"The role of surgery in endometrial cancer","volume":"35","author":"Giede","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"R58-20230824","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"R59-20230824","doi-asserted-by":"crossref","first-page":"500.e1","DOI":"10.1016\/j.ajog.2012.03.027","article-title":"The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis","volume":"206","author":"Bendifallah","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R60-20230824","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bulcan.2015.04.001","article-title":"Morbidity of pelvic lymphadenectomy and para-aortic lymphadenectomy in endometrial cancer","volume":"102","author":"Agar","year":"2015","journal-title":"Bull Cancer"},{"key":"R61-20230824","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1245\/s10434-012-2390-7","article-title":"Comparison of diagnostic accuracy of frozen section with imprint cytology for intraoperative examination of sentinel lymph node in early-stage endometrial cancer: results of Senti-Endo study","volume":"19","author":"Ballester","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R62-20230824","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jso.21200","article-title":"Issues surrounding lymphadenectomy in the management of endometrial cancer","volume":"99","author":"Bernardini","year":"2009","journal-title":"J Surg Oncol"},{"key":"R63-20230824","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.pgp.0000092136.88121.c4","article-title":"Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis","volume":"22","author":"Yasunaga","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R64-20230824","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.11.032","article-title":"Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology","volume":"102","author":"Lutman","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R65-20230824","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/jog.12399","article-title":"Clinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer","volume":"40","author":"Tomisato","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R66-20230824","doi-asserted-by":"crossref","first-page":"457.e1","DOI":"10.1016\/j.ajog.2008.01.010","article-title":"Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?","volume":"198","author":"Abu-Rustum","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R67-20230824","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPVQVBBRPT4IHD","article-title":"Value of additional level sections in the evaluation of lymph nodes for endometrial carcinoma staging","volume":"140","author":"Schmolze","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R68-20230824","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/IGC.0000000000000510","article-title":"Impact of lymph node ratio and adjuvant therapy in node-positive endometrioid endometrial cancer","volume":"25","author":"Fleming","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R69-20230824","first-page":"3","article-title":"Pattern of lymph node metastasis may define prognosis in endometrial cancer, but will it influence treatment approach?","volume":"4","author":"Barakat","year":"2001","journal-title":"Abstr Hematol Oncol"},{"key":"R70-20230824","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/IGC.0b013e3182954da8","article-title":"Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging","volume":"23","author":"Kim","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"R71-20230824","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1245\/s10434-012-2683-x","article-title":"Sentinel node biopsy upstages patients with presumed low- and intermediate-risk endometrial cancer: results of a multicenter study","volume":"20","author":"Ballester","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R72-20230824","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ygyno.2014.09.011","article-title":"Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study","volume":"136","author":"Darai","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R73-20230824","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1245\/s10434-015-5040-z","article-title":"Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma","volume":"23","author":"St Clair","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R74-20230824","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2017.09.014","article-title":"Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer","volume":"147","author":"Touhami","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R75-20230824","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2015.04.008","article-title":"Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer","volume":"138","author":"Touhami","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R76-20230824","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ajog.2016.11.1033","article-title":"Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis","volume":"216","author":"Bodurtha Smith","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R77-20230824","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/PGP.0000000000000415","article-title":"Ultrastaging of sentinel lymph nodes in endometrial carcinoma according to use of 2 different methods","volume":"37","author":"Euscher","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R78-20230824","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PGP.0000000000000113","article-title":"Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?","volume":"34","author":"Winer","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R79-20230824","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/modpathol.2010.91","article-title":"Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomies","volume":"23","author":"Folkins","year":"2010","journal-title":"Mod Pathol"},{"key":"R80-20230824","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ijgc-00009577-200301000-00009","article-title":"Relationship between the classification of vascular invasion severity and the prognosis of uterine endometrial cancer","volume":"13","author":"Kuroki","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"R81-20230824","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"R82-20230824","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ygyno.2003.11.012","article-title":"Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer","volume":"92","author":"Alexander-Sefre","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R83-20230824","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/gyno.1995.1148","article-title":"The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining","volume":"57","author":"Tsuruchi","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R84-20230824","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1200\/JCO.2008.18.6296","article-title":"Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome","volume":"26","author":"Westin","year":"2008","journal-title":"J Clin Oncol"},{"key":"R85-20230824","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.7314\/APJCP.2014.15.15.6353","article-title":"Risk factors of lymph node metastases with endometrial carcinoma","volume":"15","author":"Cetinkaya","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R86-20230824","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/138920211794520169","article-title":"Carcinoma of the lower uterine segment (LUS): clinicopathological characteristics and association with lynch syndrome","volume":"12","author":"Masuda","year":"2011","journal-title":"Curr Genomics"},{"key":"R87-20230824","first-page":"73","article-title":"Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion and lymph node metastasis: a histologic pattern mimicking intravascular and sinusoidal histiocytes","volume":"24","author":"McKenney","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"R88-20230824","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2559.2011.03802.x","article-title":"MELF invasion in endometrial cancer as a risk factor for lymph node metastasis","volume":"58","author":"Pavlakis","year":"2011","journal-title":"Histopathology"},{"key":"R89-20230824","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/PGP.0b013e31823ff422","article-title":"Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion","volume":"31","author":"Quick","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R90-20230824","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PGP.0000000000000137","article-title":"Unusual patterns of endometrial carcinoma including MELF and its relation to epithelial mesenchymal transition","volume":"33","author":"Zaino","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R91-20230824","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/PAS.0000000000000856","article-title":"Clinicopathologic association and prognostic value of microcystic, elongated, and fragmented (MELF) pattern in endometrial endometrioid carcinoma","volume":"41","author":"Kihara","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R92-20230824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/PAS.0000000000000754","article-title":"The microcystic, elongated, and fragmented (MELF) pattern of invasion: a single institution report of 464 consecutive FIGO grade 1 endometrial endometrioid adenocarcinomas","volume":"41","author":"Joehlin-Price","year":"2017","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201901001-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:38:23Z","timestamp":1692841103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201901001-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":86,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000524","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}